Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

VKTX

Viking Therapeutics Inc

34.26

Aug 07 • 3:59 PM ET +0.96 (2.88%)

34.28

Aftermarket • 7:40 PM ET +0.02 (0.06%)

Healthcare Biotechnology USA Mid NASD

Peers: MDGL AXSM ACAD KROS RYTM BMRN KYMR INCY CRNX NBIX

| Held by: VTI XBI VB VBK VXF SCHA IWR VHT DFMC IWD

Scroll to Statements

Index	-
Market Cap	4.00B
Enterprise Value	3.50B
Income	-534.80M
Sales	0.00M
Book/sh	3.50
Cash/sh	4.30
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	53
IPO	Apr 29, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	9.79
P/C	7.97
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	4.72
Current Ratio	4.72
Debt/Eq	0.01
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	-4.66
EPS next Y	-4.42
EPS next Q	-1.07
EPS this Y	-44.10%
EPS next Y	3.77%
EPS next 5Y	-4.68%
EPS past 3/5Y	-52.71% -42.46%
Sales past 3/5Y	- -
EPS Y/Y TTM	-203.77%
Sales Y/Y TTM	-
EPS Q/Q	-88.32%
Sales Q/Q	-
Earnings	Jul 29 AMC
EPS/Sales Surpr.	10.77% -

Insider Own	2.97%
Insider Trans	-5.03%
Inst Own	63.92%
Inst Trans	0.50%
ROA	-79.24%
ROE	-88.85%
ROIC	-129.73%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-2.50%
SMA50	-0.04%
SMA200	1.43%
Trades

Shs Outstand	116.65M
Shs Float	113.19M
Short Float	20.46%
Short Ratio	10.12
Short Interest	23.16M
52W High	43.15 -20.60%
52W Low	22.96 49.22%
Volatility	3.58% 4.84%
ATR (14)	1.73
RSI (14)	47.92
Beta	0.68
Rel Volume	0.61
Avg Volume	2.29M
Volume	1,402,492

Perf Week	7.94%
Perf Month	-16.72%
Perf Quarter	8.49%
Perf Half Y	30.32%
Perf YTD	-2.62%
Perf Year	-3.66%
Perf 3Y	169.55%
Perf 5Y	459.80%
Perf 10Y	2347.14%
Recom	1.21
Target Price	94.76
Prev Close	33.30
Price	34.26
Change %	2.88%

Date	Action	Analyst	Rating Change	Price Target Change
May-28-26	Initiated	Lake Street	Buy	$89
May-27-26	Resumed	Truist	Buy	$83
Mar-26-26	Initiated	Wolfe Research	Peer Perform
Oct-29-25	Initiated	Canaccord Genuity	Buy	$106
Apr-29-25	Initiated	Cantor Fitzgerald	Overweight	$104
Apr-08-25	Initiated	Goldman	Neutral	$30
Feb-13-25	Initiated	Scotiabank	Sector Outperform	$102
Feb-07-25	Initiated	Citigroup	Neutral	$38
Dec-02-24	Initiated	Piper Sandler	Overweight
Nov-22-24	Initiated	B. Riley Securities	Buy	$109
Nov-04-24	Reiterated	H.C. Wainwright	Buy	$90 → $102
Sep-11-24	Initiated	JP Morgan	Overweight	$80
Jun-27-24	Initiated	Morgan Stanley	Overweight	$105
May-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$115 → $116
Mar-26-24	Reiterated	Oppenheimer	Outperform	$116 → $138
Mar-07-24	Initiated	Jefferies	Buy	$110
Feb-28-24	Reiterated	Oppenheimer	Outperform	$46 → $116
May-31-23	Resumed	ROTH MKM	Buy	$32
Mar-28-23	Reiterated	Maxim Group	Buy	$15 → $25
Mar-17-23	Initiated	Stifel	Buy	$22

Show Previous Ratings

Jul-30-26 01:00PM	VKTX Launches $500M Shelf After Full Enrollment Of Phase 3 Obesity Drug Study Retail Bets On Exceptionally Great Data (Stocktwits)
03:22AM	VKTX Stock Lags GLP-1 Peers In July But Viking CEO Says Its Obesity Drug Could Offer What Rivals Cant (Stocktwits)
01:03AM	Viking Therapeutics Inc (VKTX) (Q2 2026) Earnings Call Highlights: Advancing Obesity Pipeline ... (GuruFocus.com)
Jul-29-26 07:58PM	VKTX Stock Steady After-Hours On Positive Obesity Drug Pipeline Progress (Stocktwits)
04:05PM	Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update (PR Newswire)
07:05AM	Loading…
Jul-23-26 07:05AM	Viking Therapeutics Appoints Dorothy Gemmell to Board of Directors (PR Newswire) -5.15%
Jul-22-26 04:05PM	Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026 (PR Newswire)
Jul-21-26 09:00AM	A Diabetes Therapy Just Locked In Its Cell Supplier, and the Race to End Insulin Injections Is Heating Up (PR Newswire)
Jul-17-26 06:39AM	The weight-loss drugs boom is creating both winners and wipeouts: One Big Investment Idea (Yahoo Finance)
Jul-15-26 08:45AM	As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 (PR Newswire)
Jul-08-26 01:11AM	VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertexs $10B CRNX Deal? (Stocktwits) -5.15%
Jun-25-26 12:14AM	VKTX Stock Eyes Best Week In 2 Years: Retail Bulls Bet Q3 Obesity Data Could Put Novo, Big Pharma In Buyout Play (Stocktwits)
Jun-24-26 02:57PM	VKTX Stock On Track For Five Consecutive Days Of Gains Viking Launches Human Trial For Novel Obesity Drug VK3019 (Stocktwits) +8.79%
07:05AM	Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults (PR Newswire)
Jun-23-26 07:46PM	VKTX Stock Clocks Best Day In Nearly 3 Months On Obesity Pipeline Optimism, Buyout Speculation (Stocktwits) +7.54%
07:05AM	Loading…
Jun-11-26 07:05AM	Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer (PR Newswire)
Jun-02-26 07:43PM	VKTX Eyes Worst Week Since November As Trial Data Looms Wall Street Still Sees 200% Upside (Stocktwits) -6.33%
May-28-26 09:47AM	Dick's Sporting upgraded, Trade Desk initiated: Wall Street's top analyst calls (The Fly)
May-12-26 07:05AM	Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026 (PR Newswire)
May-05-26 07:05AM	Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026 (PR Newswire)
Apr-30-26 03:16AM	Viking Therapeutics Inc (VKTX) Q1 2026 Earnings Call Highlights: Strategic Advancements Amid ... (GuruFocus.com)
Apr-29-26 04:05PM	Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update (PR Newswire)
Apr-22-26 04:35PM	Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026 (PR Newswire)
Apr-14-26 08:21PM	Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic? (Quartz)
Apr-10-26 07:30AM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
Mar-26-26 07:05AM	Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735 (PR Newswire)
Mar-10-26 02:32PM	Viking Therapeutics Stock Gets RS Rating Upgrade (Investor's Business Daily)
08:03AM	Is Viking Therapeutics (VKTX) One of the Shorted Biotech Stocks to Invest in (Insider Monkey)
Mar-09-26 09:05AM	NVO Stock Sheds Nearly $50B in Market Cap in a Month: Should You Sell? (Zacks)
Mar-05-26 05:45PM	Viking Therapeutics, Inc. (VKTX) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
04:03PM	Loading…
04:03PM	Viking Therapeutics to Participate at Upcoming Investor Conferences (PR Newswire)
08:12AM	Lilly Stock Down 5% in a Month: Should You Buy Now or Steer Clear? (Zacks)
Mar-04-26 01:45AM	Raymond James Lowers Viking Therapeutics, Inc. (VKTX) Price Target Amid Optimistic Clinical Initiative Outlook (Insider Monkey)
Mar-02-26 08:50AM	Is Novo Nordisk's GLP-1 Dominance Fading After Lilly's Clinical Wins? (Zacks)
Feb-27-26 05:45PM	Why the Market Dipped But Viking Therapeutics, Inc. (VKTX) Gained Today (Zacks)
Feb-25-26 08:40AM	Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead? (Zacks)
Feb-24-26 12:00PM	Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026 (Zacks)
10:17AM	Viking Therapeutics, Inc. (VKTX): A Bull Case Theory (Insider Monkey)
Feb-23-26 04:11PM	Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin (Investor's Business Daily) +11.05%
02:29PM	Viking Therapeutics Stock Gains Amid Obesity Drug Buzz (Benzinga)
01:39PM	Banks, Asset Manager Stocks Plunge On Private Credit Panic: What's Moving Markets Monday? (Benzinga)
Feb-18-26 07:22AM	Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition? (Zacks)
Feb-17-26 11:04AM	Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk (Investor's Business Daily) +5.00%
Feb-16-26 10:26AM	NVO Crashes 21% in a Month: Is This an Indication to Sell the Stock? (Zacks)
09:40AM	Wall Street Thinks These 4 Biotech Stocks Will DoubleAt LeastThis Year (24/7 Wall St.)
Feb-13-26 11:26AM	Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market (PR Newswire)
Feb-12-26 11:31AM	Viking Therapeutics Stock Soars: What's Driving The Momentum? (Benzinga) +6.80%
10:07AM	Stocks Mixed on Strength in Chipmakers and Weakness in Cisco Systems (Barchart)
08:42AM	How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report (Zacks)
08:30AM	Viking Therapeutics, Inc. Q4 2025 Earnings Call Summary (Moby)
08:03AM	VKTX Posts Wider-Than-Expected Loss in Q4, Stock Up on Pipeline Updates (Zacks)
12:03AM	Viking Therapeutics Inc (VKTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Rising ... (GuruFocus.com)
Feb-11-26 06:02PM	Viking Therapeutics Q4 Earnings Call Highlights (MarketBeat)
05:13PM	Cisco Systems, Applovin, Viking: After-Hours Movers (Yahoo Finance Video)
04:33PM	Viking Therapeutics Stock Climbs After Q4 Report: Details (Benzinga)
04:16PM	Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update (PR Newswire)
09:54AM	Is Novo Nordisk's Turnaround Story at Risk After Weak 2026 Outlook? (Zacks)
Feb-10-26 10:49AM	Eli Lilly's 2025 Surge Sets the Stage for Another Big Year in 2026 (Zacks)
Feb-09-26 11:30AM	Robinhood, AppLovin, Rivian and More Stocks With Earnings This Week (Benzinga)
10:12AM	Hims & Hers Halts Knockoff Wegovy Pill After Just Two Days: Here's Why (Investor's Business Daily)
09:55AM	Novo Nordisk Stock Whipsawed by GLP-1 Pill Fears: Relief Ahead? (Zacks)
Feb-07-26 05:22PM	Hims & Hers Health Stops Offering Knockoff Wegovy Pill Amid FDA Crackdown (Investor's Business Daily)
Feb-04-26 04:05PM	Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026 (PR Newswire) -11.06%
Feb-03-26 07:08PM	The Smartest Growth Stock to Buy With $30 Right Now (Motley Fool)
Feb-02-26 11:00AM	AZN Obesity Pipeline to Get a Boost From Deal With China's CSPC (Zacks)
Jan-30-26 05:45PM	Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market (Zacks)
10:06AM	Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock? (Zacks)
08:47AM	Viking Therapeutics to Report Q4 Earnings: Here's What to Know (Zacks)
Jan-28-26 09:09AM	Roche Reports Upbeat Efficacy Data From Phase II Obesity Study (Zacks)
Jan-27-26 01:35PM	2 Biotech Stocks Set to Rebound in 2026 (Motley Fool)
09:41AM	Novo Nordisk vs. Viking: Which Obesity Drug Stock is the Safer Bet? (Zacks)
Jan-26-26 11:35AM	Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker? (Motley Fool)
09:15AM	How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q4 Results? (Zacks)
03:14AM	Viking Therapeutics, Inc. (VKTX) Advances Obesity Drug Development and Expands Metabolic Disease Pipeline (Insider Monkey)
Jan-24-26 08:35PM	3 Growth Stocks to Invest $1,000 in Right Now (Motley Fool)
01:35PM	The Best Stocks to Invest $40 in to Start the New Year Off Right (Motley Fool)
Jan-23-26 05:45PM	Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts (Zacks) -5.49%
05:30AM	Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 (Motley Fool)
Jan-22-26 05:50PM	Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts (Zacks)
Jan-21-26 03:41PM	2 Bargain Stocks You Can Buy for Less Than $100 Right Now (Motley Fool)
10:50AM	1 Stock That Could Soar by 175%, According to Wall Street (Motley Fool)
Jan-20-26 03:25PM	What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? (Motley Fool)
08:28AM	3 Biotech Stocks That Look Like "Sure-Fire" Winners in 2026 (MarketBeat)
Jan-19-26 03:23PM	Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All (MarketBeat)
09:59AM	Is Novo Nordisk's Oral Wegovy Driving Strong Early US Demand Already? (Zacks)
Jan-16-26 10:47AM	LLY Stock Falls After FDA Reportedly Delays Obesity Drug Ruling (Zacks) +6.40%
Jan-15-26 05:45PM	Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks) -7.16%
01:11PM	Wall Street Soars Near Records, AMD And ASML Jump 6%: What's Moving Markets Thursday? (Benzinga)
10:17AM	How Will Mounjaro and Zepbound Sales Aid LLY's Upcoming Q4 Results? (Zacks)
05:10AM	Viking Therapeutics (VKTX) Soars 11.9% on Strong Weight Loss Market Outlook (Insider Monkey)
Jan-14-26 01:25PM	Stocks Drop, Energy Sector Rises As Crude Eyes 6th Day Of Gains: What's Moving Markets Wednesday? (Benzinga) +11.89%
Jan-13-26 09:58AM	Novo Nordisk Soars 19% in a Month: How Should You Play the Stock? (Zacks)
09:06AM	Jim Cramer Says "I'm a Eli Lilly Guy" When Asked About Viking Therapeutics (Insider Monkey)
Jan-12-26 07:00AM	Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity (PR Newswire)
Jan-09-26 05:45PM	Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know (Zacks)
09:58AM	VKTX Completes Enrollment in Phase I Maintenance Study of Obesity Drug (Zacks)
07:12AM	Viking Therapeutics completes enrollment in trial of VK2735 (TipRanks)
Jan-08-26 08:38PM	Lightning Round: QXO is a buy, says Jim Cramer (CNBC TV)
09:30AM	Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet (Zacks)
07:00AM	Viking Therapeutics Announces Completion of Enrollment in Maintenance Dosing Clinical Trial of VK2735 in Obesity (PR Newswire)

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

PresidentDr. Brian Lian Ph.D.

Chief Operating OfficerMs. Marianne Mancini

Vice President of Finance & AdministrationMr. Michael Morneau

Vice President of Quality & ComplianceMs. Katherine Mercier

Senior Vice President of CommercialMr. Kenneth J. Herman M.B.A.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lian Brian	President & CEO	Jul 29 '26	Sale	33.32	148,517	4,947,888	2,572,441	Jul 29 08:07 PM
ZANTE GREG	Chief Financial Officer	Jul 29 '26	Sale	33.47	21,217	710,141	212,204	Jul 29 08:06 PM
Mancini Marianna	Chief Operating Officer	Jul 29 '26	Sale	33.47	18,217	609,636	422,760	Jul 29 08:06 PM
BRIAN LIAN	Officer	Jul 29 '26	Proposed Sale	33.32	148,517	4,947,888		Jul 29 04:18 PM
GREG ZANTE	Officer	Jul 29 '26	Proposed Sale	33.47	21,217	710,141		Jul 29 04:04 PM
MARIANNA MANCINI	Officer	Jul 29 '26	Proposed Sale	33.47	18,217	609,636		Jul 29 04:03 PM
Aubuchon Neil William	Chief Commercial Officer	Mar 10 '26	Buy	33.50	4,475	149,912	4,475	Mar 10 06:20 PM
ZANTE GREG	Chief Financial Officer	Jan 05 '26	Sale	32.90	57,661	1,896,969	189,891	Jan 05 08:31 PM
Mancini Marianna	Chief Operating Officer	Jan 05 '26	Sale	32.98	57,661	1,901,405	409,190	Jan 05 08:31 PM
Lian Brian	President & CEO	Jan 05 '26	Sale	32.96	233,409	7,692,121	2,499,291	Jan 05 08:28 PM
FOEHR MATTHEW W	Director	Jan 02 '26	Option Exercise	3.33	16,000	53,280	148,036	Jan 05 08:25 PM
FOEHR MATTHEW W	Director	Jan 02 '26	Sale	35.11	16,000	561,694	132,036	Jan 05 08:25 PM
MARIANNA MANCINI	Officer	Jan 05 '26	Proposed Sale	32.98	57,661	1,901,406		Jan 05 04:32 PM
GREG ZANTE	Officer	Jan 05 '26	Proposed Sale	32.98	57,661	1,901,470		Jan 05 04:30 PM
BRIAN LIAN	Officer	Jan 05 '26	Proposed Sale	32.96	233,409	7,692,134		Jan 05 04:29 PM
MATTHEW W. FOEHR	Director	Jan 02 '26	Proposed Sale	35.11	16,000	561,694		Jan 02 04:46 PM
Mancini Marianna	Chief Operating Officer	Oct 28 '25	Sale	35.00	6,185	216,492	382,467	Oct 28 07:51 PM
Rowland Charles A Jr	Director	Oct 27 '25	Sale	35.57	60,000	2,134,278	30,000	Oct 28 07:49 PM
Lian Brian	President & CEO	Oct 28 '25	Sale	35.01	38,989	1,364,923	2,419,109	Oct 28 07:48 PM
ZANTE GREG	Chief Financial Officer	Oct 28 '25	Sale	35.00	6,185	216,481	173,592	Oct 28 07:47 PM
GREG ZANTE	Officer	Oct 28 '25	Proposed Sale	35.01	6,185	216,531		Oct 28 04:34 PM
MARIANNA MANCINI	Officer	Oct 28 '25	Proposed Sale	35.00	6,185	216,492		Oct 28 04:32 PM
BRIAN LIAN	Officer	Oct 28 '25	Proposed Sale	35.01	38,989	1,364,923		Oct 28 04:27 PM
CHARLES A ROWLAND JR.	Director	Oct 27 '25	Proposed Sale	35.57	60,000	2,134,278		Oct 27 04:25 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VKTX

Viking Therapeutics Inc

Upgrade your Finviz experience